Literature DB >> 22981944

Elements of ribosomal drug resistance and specificity.

Gregor M Blaha1, Yury S Polikanov, Thomas A Steitz.   

Abstract

The structures of ribosomes in complex with inhibitors of translation have not only shed light on the interactions of antibiotics with the ribosome but also on the underlying mechanisms by which they interfere with the ribosome function. Several recent papers [1(•),2(••),3,4] have correlated the available ribosome structures with the wealth of biochemical data [5(•)]. In this review we shall focus on the lessons learned for drug specificity rather than presenting a comprehensive survey of the known structures of ribosome complexes with antibiotics.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981944      PMCID: PMC5560274          DOI: 10.1016/j.sbi.2012.07.016

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  57 in total

1.  Recognition of cognate transfer RNA by the 30S ribosomal subunit.

Authors:  J M Ogle; D E Brodersen; W M Clemons ; M J Tarry; A P Carter; V Ramakrishnan
Journal:  Science       Date:  2001-05-04       Impact factor: 47.728

2.  The structural basis of ribosome activity in peptide bond synthesis.

Authors:  P Nissen; J Hansen; N Ban; P B Moore; T A Steitz
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

Review 3.  Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity - lessons to be learned.

Authors:  E C Böttger
Journal:  Cell Mol Life Sci       Date:  2007-04       Impact factor: 9.261

4.  Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia.

Authors:  Glòria Garrabou; Alejandro Soriano; Sònia López; Jordi P Guallar; Marta Giralt; Francesc Villarroya; Jose A Martínez; Jordi Casademont; Francesc Cardellach; Josep Mensa; Oscar Miró
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

Review 5.  Pharmacologic effects on mitochondrial function.

Authors:  Bruce H Cohen
Journal:  Dev Disabil Res Rev       Date:  2010

6.  Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.

Authors:  Rashid Akbergenov; Dmitri Shcherbakov; Tanja Matt; Stefan Duscha; Martin Meyer; Daniel N Wilson; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

7.  The theoretical basis of Paul Ehrlich's chemotherapy.

Authors:  J Parascandola
Journal:  J Hist Med Allied Sci       Date:  1981-01       Impact factor: 2.088

Review 8.  Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.

Authors:  Krishna Kannan; Alexander S Mankin
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

9.  Antibiotic susceptibility of the peptidyl transferase locus of bovine mitochondrial ribosomes.

Authors:  N D Denslow; T W O'Brien
Journal:  Eur J Biochem       Date:  1978-11-15

10.  U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome.

Authors:  Güliz Gürel; Gregor Blaha; Peter B Moore; Thomas A Steitz
Journal:  J Mol Biol       Date:  2009-04-09       Impact factor: 5.469

View more
  12 in total

Review 1.  Ribosome-targeting antibiotics and mechanisms of bacterial resistance.

Authors:  Daniel N Wilson
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

2.  Phenotypic Suppression of Streptomycin Resistance by Mutations in Multiple Components of the Translation Apparatus.

Authors:  Jennifer F Carr; Hannah J Lee; Joshua B Jaspers; Albert E Dahlberg; Gerwald Jogl; Steven T Gregory
Journal:  J Bacteriol       Date:  2015-07-06       Impact factor: 3.490

3.  Blasticidin S inhibits translation by trapping deformed tRNA on the ribosome.

Authors:  Egor Svidritskiy; Clarence Ling; Dmitri N Ermolenko; Andrei A Korostelev
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-03       Impact factor: 11.205

4.  Structural analysis of base substitutions in Thermus thermophilus 16S rRNA conferring streptomycin resistance.

Authors:  Hasan Demirci; Frank V Murphy; Eileen L Murphy; Jacqueline L Connetti; Albert E Dahlberg; Gerwald Jogl; Steven T Gregory
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

5.  Structural basis for the inhibition of the eukaryotic ribosome.

Authors:  Nicolas Garreau de Loubresse; Irina Prokhorova; Wolf Holtkamp; Marina V Rodnina; Gulnara Yusupova; Marat Yusupov
Journal:  Nature       Date:  2014-09-10       Impact factor: 49.962

Review 6.  Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.

Authors:  Jinzhong Lin; Dejian Zhou; Thomas A Steitz; Yury S Polikanov; Matthieu G Gagnon
Journal:  Annu Rev Biochem       Date:  2018-03-23       Impact factor: 27.258

7.  Deletion of L4 domains reveals insights into the importance of ribosomal protein extensions in eukaryotic ribosome assembly.

Authors:  Michael Gamalinda; John L Woolford
Journal:  RNA       Date:  2014-09-22       Impact factor: 4.942

8.  The standalone aminopeptidase PepN catalyzes the maturation of blasticidin S from leucylblasticidin S.

Authors:  Guiyang Yu; Li Li; Xiangyang Liu; Guang Liu; Zixin Deng; Mark T Zabriskie; Ming Jiang; Xinyi He
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

9.  Small molecules that target group II introns are potent antifungal agents.

Authors:  Olga Fedorova; G Erik Jagdmann; Rebecca L Adams; Lin Yuan; Michael C Van Zandt; Anna Marie Pyle
Journal:  Nat Chem Biol       Date:  2018-10-15       Impact factor: 15.040

10.  Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition.

Authors:  Matthieu G Gagnon; Raktim N Roy; Ivan B Lomakin; Tanja Florin; Alexander S Mankin; Thomas A Steitz
Journal:  Nucleic Acids Res       Date:  2016-01-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.